Selected article for: "cell cell fusion and MERS cov"

Author: Qing, Enya; Hantak, Michael; Perlman, Stanley; Gallagher, Tom
Title: Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection
  • Document date: 2020_2_11
  • ID: 1mowsbjy_20
    Snippet: This study revealed S-protein mutations that may endow CoVs with expanded tropisms, beyond that determined by prototype proteinaceous CoV receptors. The JHM-CoV mutation G176E, engineered to reflect sialate-utilizing B-CoV, increased viral S-protein binding to cells, as well as S-protein-mediated membrane fusion, independently of mCEACAM. The MERS-CoV mutation N222D, an adaptation for virus growth in mouse lungs (58) , operated remarkably similar.....
    Document: This study revealed S-protein mutations that may endow CoVs with expanded tropisms, beyond that determined by prototype proteinaceous CoV receptors. The JHM-CoV mutation G176E, engineered to reflect sialate-utilizing B-CoV, increased viral S-protein binding to cells, as well as S-protein-mediated membrane fusion, independently of mCEACAM. The MERS-CoV mutation N222D, an adaptation for virus growth in mouse lungs (58) , operated remarkably similar to the JHM-CoV G176E change, with mutant S proteins showing increased hDPP4-independent cell binding and cell fusion. Our findings fit with the hypothesis that viruses with these mutations bind relatively tightly to sialoside receptors. However, it is clear that the changes are not present in currently identified sialoside-binding sites (18, 54) , which raises alternative hypotheses that include mutation-induced allosteric restructuring of sialoside-binding sites. Alternatively, the mutations may restructure distinct receptor-or coreceptor-binding sites, such as presumed binding sites for orthologous CEACAMs on MHV S proteins (69), or sites for CEACAM5 (70) or GRP78 (71) on MERS-CoV S proteins.

    Search related documents:
    Co phrase search for related documents
    • alternative hypothesis and CoV receptor: 1
    • alternative hypothesis and MERS cov: 1
    • bind site and cell binding: 1, 2, 3, 4, 5, 6, 7
    • bind site and cell fusion: 1
    • bind site and CoV receptor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • bind site and currently identify: 1
    • bind site and distinct receptor: 1
    • bind site and membrane fusion: 1
    • bind site and MERS cov: 1, 2, 3
    • cell binding and CoV receptor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell binding and distinct receptor: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • cell binding and expand tropism: 1
    • cell binding and JHM CoV mutation: 1, 2
    • cell binding and membrane fusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell binding and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell binding and MERS cov mutation: 1
    • cell binding cell fusion and CoV receptor: 1, 2
    • cell binding cell fusion and distinct receptor: 1
    • cell binding cell fusion and expand tropism: 1